Bank of America named several stocks that are well positioned ahead of the rest of earnings season. The Wall Street investment bank says companies like Uber are too attractive to ignore. Other buy-rated names screened by CNBC Pro include: Datadog , Doximity, RB Global and Futu. Doximity The social platform for physicians is firing on all cylinders, according to the Bank of America. Analyst Allen Lutz recently lifted his rating on the stock ahead of earnings in early November to buy from neutral. The firm conducted a recent study that says the company is a beneficiary of the Food and Drug Administration’s crackdown on pharmaceutical direct-to-consumer advertising. Lutz said it confirms his thesis that ad dollars are likely to shift to Doximity’s platform. “Separately, spend on DOCS’ platform is expected to increase 1.7%, the largest rise in our 14 surveys,” he wrote. Shares of the company are up 24% this year. RB Global Buy the dip in shares of the automotive and industrial equipment auction company, according to analyst Michael Feniger. “After RBA share price pull back, we believe risk-reward is turning more favorable,” he wrote. The firm says 2026 is shaping up to be the company’s “first clean year” with RB Global well on its way to being a solid double-digit compounder. “RB is a high quality company with strong market share, strong [free cash flow] generation, and favorable long-term growth drivers,” he wrote. The stock is up almost 10% this year ahead of the company’s scheduled earnings report in early November. Datadog Meanwhile, analyst Koji Ikeda is bullish on the cloud-scale application company ahead of its earnings on Nov. 6. “We expect Datadog to deliver upside to Street estimates given our increased confidence that strong demand continues for its leading platform of observability and security tools,” he wrote. The firm believes the stock is well positioned for AI and raised its price target to $180 per share from $175. “With AI workloads beginning to pick up, we believe Datadog will be a beneficiary in the AI theme,” he said. Meanwhile, the stock is up almost 14% this year with more room to run. “As more AI experiences become available, it’s likely going to be a share gainer,” he added. Here’s what else Bank of America analysts had to say. Doximity “We conducted our fourteenth quarterly survey on pharma advertising spend (see our July survey). The survey validates our initial hypothesis that the FDA’s recent crackdown on pharmaceutical direct-to-consumer advertising could shift advertising dollars to Doximity’s platform. … Separately, spend on DOCS’ platform is expected to increase 1.7%, the largest rise in our 14 surveys.” FUTU “Reiterate Buy on Futu for diversified market exposure, robust client & [assets under management] growth and promising developments in key markets & products. … We rate Futu at Buy for its diversified market exposure, robust client & AUM growth, encouraging developments in overseas markets & new products, as well as improving [Hong Kong]/China market sentiments.” RB Global “After RBA share price pull back, we believe risk-reward is turning more favorable. …. 2026 is RB’s first ‘clean year.’ … RB is a high quality company with strong market share, strong FCF generation, and favorable long-term growth drivers.” Uber “Uber should benefit from secular shifts to the sharing economy (Mobility), time saving services (Delivery), and a move to more efficient marketplaces (Freight). We are constructive on fundamentals given a large total addressable market (TAM) and technology advances that likely lower driver dependency and improve margins.” Datadog “We expect Datadog to deliver upside to Street estimates given our increased confidence that strong demand continues for its leading platform of observability and security tools. … As more AI experiences become available, it’s likely going to be a share gainer. … With AI workloads beginning to pick up, we believe Datadog will be a beneficiary in the AI theme.”